Multiple sclerosis (MS) is a debilitating disease of the brain and spinal cord that impacts millions worldwide. With MS, the immune system mistakenly attacks the myelin sheath—a protective layer ...

Intrathecal baclofen (ITB) therapy is an established treatment for severe refractory spasticity. Although a positive ITB ...

Improving Multiple Sclerosis Care for Black Patients "Medical Journeys" is a set of clinical resources reviewed by doctors, meant for physicians and other healthcare professionals as well as the ...

In this case-control study, visual disturbances, gastritis, heartbeat abnormalities, joint abnormalities, skin sensation disturbances, dizziness, and obesity were more common among children 18 years ...

Please provide your email address to receive an email when new articles are posted on . A total of 32% of patients with radiological-only onset and 17% with atypical onset met the new criteria.

A team of scientists from the New York Stem Cell Foundation (NYSCF) Research Institute and Case Western Reserve University has created the largest reported collection of stem cell models from multiple ...

Fast Five Quiz: Relapsing-Remitting Multiple Sclerosis Management How familiar are you with the management of RRMS? Test your knowledge with this quick quiz.

Stifel on Thursday initiated coverage on Immunic Inc. IMUX, a late-stage biotechnology company developing oral therapies for neurologic and gastrointestinal diseases. The company’s lead development ...

A team of scientists led by the Institute for Glial Sciences (IGS) at Case Western Reserve University's School of Medicine has discovered a built-in "brake" that controls when key brain cells mature.

Multiple sclerosis (MS) treatment could be on the brink of a significant breakthrough thanks to innovative research by Immunic Therapeutics. Speaking to Fierce Pharma, CEO Daniel Vitt shares insights ...